Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Council Members in Member Programs who Treat Fusarium Keratitis

Articles with lock require a subscription to GLG News | Request a free trial
Steve RubinsteinNovember 13, 2008
Will contact lens solutions cost more to ship and store?
Analysis of: Eye Infection Epidemic Traced To Reduced Antifungal Properties Of Contact Lens Solution In High Temperatures | www.medicalnewstoday.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
A new study in Archives of Ophthalmology, November 2008 indicates that a reason for the large number of infections from Bausch & Lomb's Renu Moisture Loc solution was due to poor temperature control reducing antifungal and antimicrobial efficacy.
Steve RubinsteinNovember 4, 2008
Lasik, Pharma, and Cataracts...are they recession proof?
Analysis of: Value Stocks in the Eye of the Storm? | news.morningstar.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
The article goes into the four major eye care markets that have a mix of reimbursed, and consumer driven areas. It describes the issues I face as a provider of these products. 
Steve RubinsteinOctober 6, 2008
A new lens for computer users?
Analysis of: PixelOptics focuses on new lens | www.roanoke.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
This eyeglass lens designer, Ron Blum has created a new type of Progressive Addition Lens about 6 years ago. It created a new market in Ultra-Premium lenses. Now he is attempting to create a new lens for computer users. I look forward to its introduction next month, and to the creation of new profit...
Steve RubinsteinSeptember 22, 2008
Working with Silcione Hydrogels is not easy!
Analysis of: Ahead of the Bell: Cooper Cos. | www.forbes.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
This article mentions two major contact lens manufacturers, CooperVision and Vistakon (a subsidiary of Johnson & Johnson), with difficulties actually making silicone hydrogel contact lenses that can be sold successfully.
Steve RubinsteinSeptember 22, 2008
A new Contact Lens material by 2009?
Analysis of: Ocutec wins backing for contact lens venture | www.theherald.co.uk
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
A new material that is easier to produce contact lenses with may decrease the cost of producing contact lenses. A major difficulty in producing today's silicone hydrogels is production costs. 
September 19, 2008
Overdramatization
Analysis of: CooperVision Introduces Avaira™ Two-Week Silicone Hydrogel Contact Lenses | www.coopervision.com
Author: GLG Expert Contributor
To assert that Cooper needs the Avaira to be successful to be a player in the soft contact lens market is simply overly dramatic. Cooper has one of the largest portfolios of soft contact lens product of all of the big 4 manufacturers - B&L, Ciba, and Vistakon.  They have...
Steve RubinsteinAugust 26, 2008
New non steroidal anti-inflamatory for diabetic retinopathy?
Analysis of: Pfizer Inc. Cancels Phase III of Glaucoma Drug Research in Asia | www.biospace.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
The new prostaglandin analog is not what i find interesting in this article. A new treatment for Diabetic Retinopathy sounds much more interesting
Steve RubinsteinJuly 3, 2008
An illegal use of Lumigan, now legal?
Analysis of: Longer Lashes in a Tube? Maybe Not | www.nytimes.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
A few months ago, a small company tried to import Lumigan (bimatoprost), licensed by Allergan, in an eyelash applicator. It was held by the FDA as an unapproved use of a prescription medication. Now the owner of the patent is trying to import the same drug legally.
Steve RubinsteinJune 3, 2008
Announcing the 1-Day Acuvue TruEye a New Silicone Hydrogel Contact Lens
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
This is the first announcement anywhere in the world about a daily disposable contact lens that is in a breathable silicone hydrogel material. Will it make it across the ocean?
Steve RubinsteinMay 15, 2008
Will The Avaira Take Market Share From Oaysis?
Analysis of: CooperVision Introduces Avaira™ Two-Week Silicone Hydrogel Contact Lenses | www.coopervision.com
Author: Steve Rubinstein, Optometrist, Sound Shore Vision Care
Can Cooper take over the 2 week spherical contact lens market? Can it make a dent in the market share of the industry leader in the silicone hydrogel field? Initial results look good. A definite maybe!

Page : 1 2 3 4 5 6 7 8 9 10 Next1 to 10 of 96

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T17:45:17.163